Media
Explore our latest news, events, and resources.
From educational publications to campaign highlights and upcoming activities, this section brings together all our updates to keep patients, healthcare professionals, and advocates informed and engaged in the world of radioligand therapy.
News
- News24.12.2021
Warm and Hopeful Wishes 2022
Read more - News30.11.2021
Radiotheranostics Today by the Oncidium foundation
Read more - News13.10.2021
Get more insight from the NOBLE Registry Website
Read more - News28.09.2021
Q&A: How a new imaging tool helps to better stage prostate cancer
Read more - News20.09.2021
Scandium radionuclides for theranostic applications
Read more - News08.09.2021
Patient Management with Lu-177–PSMA-617 in the Clinic
Read more
Events
- Events22-30 October 2020
EANM '20 - Let's talk Radiotheranostics!
Read more - Events11-14 July 2020
SNMMI 2020 - Virtual Edition
Read more - EventsJan 30 - Feb 01, 2020
EANM FOCUS MEETING - Theranostics for NET's
Read more - Events27 - 30 January 2020
ARAB HEALTH 2020
Read more - Events14 December 2019
SNMICON 2019
Read more - Events12-14 December 2019
International Symposium Bad Berka 2019
Read more
Videos
What Are Radiotheranostics for Cancer Care?
Doctor, will Radiotheranostics make me radioactive?
Tom, treated with PRRT for NETs
Fernando Acosta’s Testimonial with Lutetium-177 PSMA Radioligand Therapy
Links
Nuclear medicine
- The NME (Nuclear medicine Europe) has implemented a website for the general public called “What is Nuclear medicine ?”, that features movies, cartoons and special small booklets to be downloaded that explain basic concepts.
- Official bodies such as EANM and SNMMI also have materials explaining aria-describedby="qtip-67">Nuclear medicine.
- You will find useful information as well on the IAEA website about Radiopharmaceuticals production and some interesting Publications regarding advances search.
Books
In order to explain this technology in an accessible way, a reference booklet containing information on Nuclear medicine was written by the author of this project. It was initially intended for workers in the Radiopharmaceutical industry but was then used for patients and finally distributed to potential investors. This book is presently available in French, English, and Spanish.